SAR439859, a Novel Selective Estrogen Receptor Degrader (SERD), Demonstrates Effective and Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer Models

Maysoun Shomali(Sanofi (United States)), Monsif Bouaboula(Sanofi (United States))
Molecular Cancer Therapeutics
December 11, 2020
Cited by 67


Related Papers

No related papers found

Powered by citation graph analysis